![]() |
|
|
Molecular Pharmacology, Vol 14, 723-736, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics
1 Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill,
London NW7 1AA, UK
The interaction of agonists with muscarinic receptors has been investigated by measuring the binding of [3H]muscarinic agonists to membrane preparations from the rat cortex and by means of [3H]agonist/agonist and [3H]antagonist/agonist competition experiments. The binding data can be explained by the presence of two major populations of agonist binding sites which do not interconvert during the binding experiments and have the same affinity constants for antagonists. The ratio of the affinity constants of an agonist for the two sites can vary from 1 to about 275. There is quantitative agreement between the agonist affinity constants for the two sites and parameters derived from the action of muscarinic agonists on smooth muscle, A third (minor) population of "super-high" affinity agonist binding sites has been detected.
Note:
ACKNOWLEDGMENTS
The authors wish to thank P. Mehta and R. Edees
for skilled technical assistance and Drs. C. R. Hiley
and J. M. Young for their permission to include some
of their unpublished results in Table 7.
This article has been cited by other articles:
![]() |
V. Snitsarev, C. A. Whiteis, M. W. Chapleau, and F. M. Abboud Mechano- and chemosensitivity of rat nodose neurones - selective excitatory effects of prostacyclin J. Physiol., July 1, 2007; 582(1): 177 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Slutsky, G. Rashkovan, H. Parnas, and I. Parnas Ca2+-Independent Feedback Inhibition of Acetylcholine Release in Frog Neuromuscular Junction J. Neurosci., May 1, 2002; 22(9): 3426 - 3433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Waelbroeck Activation of Guanosine 5'-[{gamma}-35S]thio-triphosphate Binding through M1 Muscarinic Receptors in Transfected Chinese Hamster Ovary Cell Membranes: 1. Mathematical Analysis of Catalytic G Protein Activation Mol. Pharmacol., April 1, 2001; 59(4): 875 - 885. [Abstract] [Full Text] |
||||
![]() |
N. Ilouz, L. Branski, J. Parnis, H. Parnas, and M. Linial Depolarization Affects the Binding Properties of Muscarinic Acetylcholine Receptors and Their Interaction with Proteins of the Exocytic Apparatus J. Biol. Chem., October 8, 1999; 274(41): 29519 - 29528. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. T. Nguyen, T. X. Lee, A. Ndoye, L. D. Shultz, M. R. Pittelkow, M. V. Dahl, P. J. Lynch, and S. A. Grando The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity: Development of Antibodies Against Keratinocyte Cholinergic Receptors in Patients With Pemphigus Vulgaris and Pemphigus Foliaceus Arch Dermatol, August 1, 1998; 134(8): 971 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Vogel, D. M. Sheehan, and M. I. Schimerlik Site-Directed Mutagenesis on the m2 Muscarinic Acetylcholine Receptor: The Significance of Tyr403 in the Binding of Agonists and Functional Coupling Mol. Pharmacol., December 1, 1997; 52(6): 1087 - 1094. [Abstract] [Full Text] |
||||
![]() |
Z.-L. Lu, C. A. Curtis, P. G. Jones, J. Pavia, and E. C. Hulme The Role of the Aspartate-Arginine-Tyrosine Triad in the m1 Muscarinic Receptor: Mutations of Aspartate 122 and Tyrosine 124 Decrease Receptor Expression but Do Not Abolish Signaling Mol. Pharmacol., February 1, 1997; 51(2): 234 - 241. [Abstract] [Full Text] [PDF] |
||||